Munin et al., 2011 - Google Patents
Encapsulation of natural polyphenolic compounds; a reviewMunin et al., 2011
View HTML- Document ID
- 978821450296520524
- Author
- Munin A
- Edwards-Lévy F
- Publication year
- Publication venue
- Pharmaceutics
External Links
Snippet
Natural polyphenols are valuable compounds possessing scavenging properties towards radical oxygen species, and complexing properties towards proteins. These abilities make polyphenols interesting for the treatment of various diseases like inflammation or cancer, but …
- 150000008442 polyphenolic compounds 0 title abstract description 117
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Munin et al. | Encapsulation of natural polyphenolic compounds; a review | |
| Khalil et al. | Nanoantioxidants: Recent trends in antioxidant delivery applications | |
| Grgić et al. | Role of the encapsulation in bioavailability of phenolic compounds | |
| Yang et al. | Nanoformulations to enhance the bioavailability and physiological functions of polyphenols | |
| Detsi et al. | Nanosystems for the encapsulation of natural products: The case of chitosan biopolymer as a matrix | |
| Rahaiee et al. | Application of nano/microencapsulated phenolic compounds against cancer | |
| Parisi et al. | Polyphenols and their formulations: different strategies to overcome the drawbacks associated with their poor stability and bioavailability | |
| Fang et al. | Encapsulation of polyphenols–a review | |
| Zuccari et al. | Formulation strategies to improve oral bioavailability of ellagic acid | |
| Date et al. | Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration | |
| Ghanbarzadeh et al. | Nano-phytosome as a potential food-grade delivery system | |
| Chen et al. | Novel technology for the preparation of self-assembled catechin/gelatin nanoparticles and their characterization | |
| Ali et al. | Engineered nano scale formulation strategies to augment efficiency of nutraceuticals | |
| Anand et al. | Polyphenols and their nanoformulations: Protective effects against human diseases | |
| Kurek et al. | Antioxidants and bioactive compounds in food: Critical review of issues and prospects | |
| Klettenhammer et al. | Novel technologies based on supercritical fluids for the encapsulation of food grade bioactive compounds | |
| Sridhar et al. | Recent advances on nanoparticle based strategies for improving carotenoid stability and biological activity | |
| Martins et al. | Valorisation of micro/nanoencapsulated bioactive compounds from plant sources for food applications towards sustainability | |
| Sharaf et al. | Applying Box–Behnken design for formulation and optimization of PLGA-coffee nanoparticles and detecting enhanced antioxidant and anticancer activities | |
| Yousefi et al. | Encapsulation systems for delivery of flavonoids: A | |
| Bohara et al. | Recent overview of resveratrol’s beneficial effects and its nano-delivery systems | |
| AbouAitah et al. | Nanomedicine as an emerging technology to foster application of essential oils to fight cancer | |
| Ghosh et al. | Complexation with human serum albumin facilitates sustained release of morin from polylactic-co-glycolic acid nanoparticles | |
| Lawson | Improvement of therapeutic value of quercetin with chitosan nanoparticle delivery systems and potential applications | |
| Duvvuri et al. | Delivery aspects of antioxidants in diabetes management |